• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Analysis of the function of the new cellular protein human scribble as a tumor suppressoi and its involvement into the egg development-cross talk between the tissue polarity degermination by the human scribble and control of egg development.

Research Project

Project/Area Number 14571541
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionThe University of Tokyo

Principal Investigator

NAKAGAWA Shunsuke  The University of Tokyo, Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (70270874)

Co-Investigator(Kenkyū-buntansha) YANO Tetsu  The University of Tokyo, Faculty of Medicine, Associate Professor, 医学部附属病院, 助教授 (90251264)
Project Period (FY) 2002 – 2003
KeywordsTumor suppressor / human scribble / cervical cancer / human papillomavirus / E6 oncoprotein / intracellular localization
Research Abstract

Recently, a LAP protein. Scribble, was Identified in Drosophlla epithelia as a basolateral protein that controls the apical-basolateral polarity. Loss of Scribble causes disorganization and overgrowth of the epithelia. Scribble has a human homologue, human Scribble (hScrib). Which is a substrate of ubiquikin-mediated degradation by human papillomavirus E6 and the E6AP ubiquitin-protein Iigase. In the present study. we revcated that hScrib localized to the basolateral regions of the opithelial cell line MDCK and human utorine cervical opithelial tissues by immunoflorescence. Human Scribble co-localied rather with the adherens junction protein E-cadherin, but not with the right junction protein ZO-1. Histochemical analysis showed a dramatic decrense in the expression of hScrib with the progression of disease from normal terine carvical *issues to invasive cervical cancers through the precursor losious. In contrast, the expression of hScrib was retained in the throughout upithelial tayer of tthe HPV-negative cervical high-grade squamous intracpithelial lesions. Although quantitative RT-RCR reveated no signicant down-regulation of human scribble mRNA expresion in the high-grade squamous intracpithelial losions, it reveated a cleardown-regulation in the invasive cancers. These results suggest the possibility that degradation by HPV E6 is one of causal role for the progressive decrease of hAcrib expression during the disease progression from low-grade squamous intraopithelial lesions to high-grade squamousintracpithelial losions and a cooperative role of down-regulation of human scribble mRNA expression and ubiquitin-mediated degradation of hScrib by E6 and E6AP lead to the complete decrease of hScrib expression during the process of carcinogenesis from H-SIL to invasive cancer. These data underscore the Importance of hScrib in the construction of tissue architecture and prevention of cancer development.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Shunsuke Nakagawa: "Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix."British Journal of Cancer. 12・90(1). 194-199 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akira Namba: "Ovarian choriocarcinoma arising from partial mole as evidenced by deoxyribonucleic acid microsatellite analysis."Obstetrics & Gynecoly. 102(5 Pt 1). 991-994 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koji Matsumoto: "Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer."International Journal of Cancer.. 10;106(6). 919-922 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shin Takizawa: "Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer."British Journal of Cancer. 22;88(8). 1213-1216 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koji Matsumoto: "IgG antibodies to human papillomavirus 16,52,58,and 6 L1 capsids : case-control study of cervical intraepithelial neoplasia in Japan."Jouranal of Medical Virology. 69(3). 441-446 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kei Kawana: "Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma"American Journal of Perinatol.. 20(1). 11-16 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shunsuke Nakagawa: "Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix."British Journal of Cancer. 12・90(1). 194-199 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akira Namba: "Ovarian choriocarcinoma arising from partial mole as evidencedby deoxyribonucleic acid microsatellite analysis."Obstetrics & gynecoly. 102(5Pt1). 991-994 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koji Matsumoto: "Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer."International Journal of Cancer. 10;106(6). 919-922 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shin Takizawa: "Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer."British Journal of Cancer. 22;88(8). 1213-1216 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koji Matsumoto: "IgG antibodies to human papillomavirus 16, 52, 58, and 6 LI capsids: case-control study of cervical intraepithelial neoplasia in Japan."Journal of Medical Virology. 69(3). 441-446 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kei Kawana: "Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata."American Journal of Perinatol.. 20(1). 11-16 (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi